Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Apollo Hospitals Enterprise's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 22,196.9 | 20,657.4 | 16,753.1 |
| Accumulated Depreciation Total | -5,527.5 | -4,873.9 | -4,278.7 |
| Cash Equivalents | 797.2 | 562.9 | 13.3 |
| Other Liabilities Total | 142.5 | 136.7 | 101.3 |
| Accrued Expenses | 325.8 | 194.7 | 159.8 |
| Long Term Debt | 2,430.1 | 4,417 | 2,235.6 |
| Common Stock Total | 71.9 | 71.9 | 71.9 |
| Other Equity Total | -34.3 | -92 | -87 |
| Other Current Assets Total | 319 | 794.6 | 368 |
| Prepaid Expenses | 143 | 119.9 | 105.9 |
| Total Assets | 22,196.9 | 20,657.4 | 16,753.1 |
| Current Portof LT Debt/Capital Leases | 2,906.5 | 511.7 | 444 |
| Additional Paid-In Capital | 2,863.7 | 2,863.7 | 2,863.7 |
| Cash | 14.1 | 15.2 | 492.2 |
| Total Equity | 9,480.1 | 8,212.3 | 6,935.4 |
| Long Term Investments | 1,338.4 | 1,105.6 | 345.6 |
| Retained Earnings(Accumulated Deficit) | 6,578.8 | 5,360.9 | 4,079 |
| Total Common Shares Outstanding | 14.38 | 14.38 | 14.38 |
| Property/Plant/Equipment Total-Gross | 17,557.7 | 15,460.8 | 13,664 |
| Tangible Book Valueper Share Common Eq | 570.88 | 479.37 | 402.5 |
| Goodwill Net | 1,032.3 | 1,030.5 | 1,012.3 |
| Total Liabilities | 12,716.8 | 12,445.1 | 9,817.7 |
| Total Debt | 8,492.9 | 7,864.3 | 5,332.6 |
| Short Term Investments | 1,044.6 | 1,432.2 | 852.7 |
| Cashand Short Term Investments | 1,855.9 | 2,010.3 | 1,358.2 |
| Total Receivables Net | 3,941.9 | 3,432.6 | 2,825.1 |
| Notes Payable/Short Term Debt | 486 | 521.7 | 671.6 |
| Deferred Income Tax | 498.2 | 458 | 449.8 |
| Accounts Receivable-Trade Net | 3,678.3 | 3,205.8 | 2,672.1 |
| Property/Plant/Equipment Total-Net | 12,030.1 | 10,586.7 | 9,385.2 |
| Minority Interest | 494.4 | 440.6 | 385.1 |
| Total Current Liabilities | 6,481.3 | 4,578.9 | 4,664.5 |
| Total Inventory | 640 | 671.5 | 622.5 |
| Accounts Payable | 2,251.8 | 2,240.5 | 2,368.6 |
| Other Currentliabilities Total | 511.2 | 1,110.3 | 1,020.5 |
| Total Long Term Debt | 5,100.4 | 6,830.9 | 4,217 |
| Intangibles Net | 239.4 | 289.2 | 135.8 |
| Other Long Term Assets Total | 201.8 | 197.4 | 237.8 |
| Note Receivable-Long Term | 455.1 | 419.1 | 356.7 |
| Total Current Assets | 6,899.8 | 7,028.9 | 5,279.7 |
| Capital Lease Obligations | 2,670.3 | 2,413.9 | 1,981.4 |
| Unrealized Gain(Loss) | Not available | 7.8 | 7.8 |
PEG Ratio1.98
Price to Sale Ratio5.02
Debt 5Yr CAGR %15.35
Operating Margin 12m11.39
Operating Margin 5y Avg10.49
Net Profit Margin 12m7.76
Net Profit Margin 5y6.51
Dividend Yield %0.22
Overall RiskModerate risk
Board Risk17.97
ConsensusStrong Buy
Consensus score1.74
Analyst opinions27
Strong Sell count0
Sell count1
Hold count3
Buy count11
Strong Buy count12
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Max Healthcare Institute | INR 1,075 | 1.05 L | 71.47 | — |
| Fortis Healthcare | INR 935 | 70,588.59 | 67.89 | — |
| Aster DM Healthcare | INR 844.4 | 44,157.18 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,881 | 38,187.34 | 48.07 | — |
| Global Health | INR 1,440.1 | 38,871.79 | 63.65 | — |
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Apollo Hospitals Brings Next-Generation Lysin Science to India's Fight Against AMR - Collaborates with Precisio Biotix Yahoo Finance Singapore
Apollo Hospitals stock trades steady as profit rises and expansion supports growth Ad-hoc-news.de
Medtronic, Apollo Hospitals Launch Advanced ICU in Hyderabad to Strengthen Critical Care eHealth Magazine
Apollo Hospitals schedules Q1 earnings call on August 13, 2026 scanx.trade
Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad Business Standard
Apollo Hospitals Enterprise - Sun Pharma among 5 stocks that hit 52-week highs & rallied up to 20% in a month The Economic Times
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Apollo Hospitals Enterprise Limited is an integrated healthcare company. It is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. It is engaged in hospitals and hospitals-based services. The Company's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. The Retail Health and Diagnostics segment include clinics, diagnostics, Spectra, Cradle, Sugar, Dental and Dialysis business. The Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast-moving consumer goods and private label products business from various services using the digital platform. The Company has approximately 10,100 plus beds across 73 hospitals and 6,600 plus pharmacies.
Apollo Hospitals Enterprise has the symbol APOLLOHOSP and ISIN - INE437A01024.
Apollo Hospitals Enterprise is currently trading at INR 8,735.00.
Apollo Hospitals Enterprise has a year high of INR 9,050.00 and a year low of INR 6,696.50.
Apollo Hospitals Enterprise has a market capitalization of INR 1.27 lakh crore.
Apollo Hospitals Enterprise has a P/E ratio of 54.94.
Apollo Hospitals Enterprise has a dividend yield of 0.22%.
Apollo Hospitals Enterprise has revenue of INR 25,228.50 crore, net income of INR 1,941.70 crore, and EPS of INR 135.95.
Apollo Hospitals Enterprise has a book value of INR 570.88.
Apollo Hospitals Enterprise has a debt-to-equity ratio of NA.
Apollo Hospitals Enterprise has a price-to-book ratio of 15.30 and a price-to-sales ratio of 5.02.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.